Recent Finacing
Recent Raise
FASgen is a Baltimore-based drug development company researching inhibition of the fatty acid biosynthesis pathway to develop therapeutics for metabolic disease and obesity, collaborating with Johns Hopkins laboratories.
Recent Investors
Total Raised
Funding round
Investor